Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Gross Profit (2020 - 2025)

Historic Gross Profit for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $4.9 million.

  • Biofrontera's Gross Profit rose 1954.05% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 239.09%. This contributed to the annual value of $18.7 million for FY2024, which is 1255.19% up from last year.
  • Biofrontera's Gross Profit amounted to $4.9 million in Q3 2025, which was up 1954.05% from $6.4 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Gross Profit registered a high of $12.0 million during Q4 2023, and its lowest value of -$7.3 million during Q4 2022.
  • Moreover, its 5-year median value for Gross Profit was $4.3 million (2022), whereas its average is $4.5 million.
  • The largest annual percentage gain for Biofrontera's Gross Profit in the last 5 years was 26303.37% (2023), contrasted with its biggest fall of 20573.75% (2023).
  • Quarter analysis of 5 years shows Biofrontera's Gross Profit stood at $9.0 million in 2021, then tumbled by 181.57% to -$7.3 million in 2022, then skyrocketed by 263.03% to $12.0 million in 2023, then crashed by 39.02% to $7.3 million in 2024, then tumbled by 32.18% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q3 2025, $6.4 million for Q2 2025, and $5.3 million during Q1 2025.